CIK 0001374690 · Non-accelerated filer<br>Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203857670
- Phone
- 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $382,086
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$382,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-29 | THOMAS FRANK E Director | Grant or award · Stock Option (right to buy) | +16,600 | 16,600 | ||
| 2020-09-29 | BEN-MAIMON CAROLE President and CEO | Grant or award · Stock Option (right to buy) | +411,400 | 411,400 | ||
| 2020-06-26 | Hamilton Thomas Edward Director | Other acquisition | +133,420 | 133,420 | ||
| 2020-06-26 | Hamilton Thomas Edward Director | Other acquisition | +159,433 | 292,853 | ||
| 2020-06-26 | CHONDRIAL THERAPEUTICS HOLDINGS, LLC 10% owner | Other disposition | −6,091,242 | 8 | ||
| 2020-06-26 | BEN-MAIMON CAROLE President and CEO | Other acquisition | +25,083 | 25,083 | ||
| 2020-05-28 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +60,479 | 60,479 | ||
| 2019-06-26 | EVERETT WENDY Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2019-06-26 | McDonough Cameron Geoffrey Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2019-06-26 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2019-06-26 | THOMAS FRANK E Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2019-06-26 | Daniel Thomas O Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2019-06-26 | Barrett Peter Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2019-06-26 | LAMATTINA JOHN L Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2019-04-02 | Singhal Priya Head of Research & Development | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2019-01-24 | Barrett Peter Director | Grant or award · Stock Option (Right to Buy) | +21,396 | 21,396 |
Page 7 of 7 · 136 trades